Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127109311 | 12710931 | 1 | I | 20160825 | 20160902 | 20160902 | EXP | PE-PFIZER INC-2016406325 | PFIZER | 54.00 | YR | F | Y | 0.00000 | 20160902 | CN | PE | PE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127109311 | 12710931 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | 40 MG, DAILY | U | 20702 | 40 | MG | FILM-COATED TABLET | |||||||
127109311 | 12710931 | 2 | C | ATLANSIL | AMIODARONE | 1 | UNK | 0 | |||||||||||
127109311 | 12710931 | 3 | C | ELIQUIS | APIXABAN | 1 | UNK | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127109311 | 12710931 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127109311 | 12710931 | Cerebral infarction | |
127109311 | 12710931 | Gait disturbance | |
127109311 | 12710931 | Monoplegia | |
127109311 | 12710931 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |